Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome

被引:71
作者
Cheung, L. P. [1 ]
Ma, R. C. W. [2 ]
Lam, P. M. [1 ]
Lok, I. H. [1 ]
Haines, C. J. [1 ]
So, W. Y. [2 ]
Tong, P. C. Y. [2 ]
Cockram, C. S. [2 ]
Chow, C. C. [2 ]
Goggins, W. B. [3 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China
关键词
polycystic ovary syndrome; metabolic syndrome; Chinese;
D O I
10.1093/humrep/den090
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Women with polycystic ovary syndrome (PCOS) frequently exhibit central obesity, glucose intolerance, atherogenic dyslipidaemia and hypertension which are characteristic features of the metabolic syndrome (MetS). METHODS: A total of 295 premenopausal Chinese women with PCOS diagnosed by the Rotterdam criteria (mean age: 30.2 +/- 6.4 years) and 98 control subjects without PCOS were evaluated for prevalence of MetS and cardiovascular risk factors, including dyslipidaemia and dysglycaemia. RESULTS: Using the 2005 modified Adult Treatment Panel III criteria, MetS (presence of three or more risk factors) was found in 24.9% of PCOS women compared to 3.1% of controls. The prevalence of MetS in PCOS women increased from 16.7% at under 30 years of age to 53.3% at over 40 years. MetS was also more prevalent in overweight and obese (41.3%) than normal-weight PCOS women (0.9%). However, multivariate regression analysis showed that women with PCOS had a 5-fold increase in risk of MetS (odds ratio 4.90; 95% confidence interval: 1.35-17.84) compared with women without PCOS even after controlling for age and BMI, suggesting PCOS alone is an independent risk factor for MetS. CONCLUSIONS: There is high prevalence of MetS in Hong Kong Chinese women with PCOS despite their relatively young age. Recognition of these cardiometabolic risk factors requires a high level of awareness in conjunction with early and regular screening.
引用
收藏
页码:1431 / 1438
页数:8
相关论文
共 49 条
[1]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[2]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[3]   HYPERSECRETION OF LUTEINIZING-HORMONE AND THE POLYCYSTIC-OVARY-SYNDROME [J].
BALEN, AH .
HUMAN REPRODUCTION, 1993, 8 :123-128
[4]   Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS [J].
Carmina, E ;
Napoli, N ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) :141-145
[5]   Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome [J].
Chen, Xiaoli ;
Yang, Dongzi ;
Li, Lin ;
Feng, Shuying ;
Wang, Liangan .
HUMAN REPRODUCTION, 2006, 21 (08) :2027-2032
[6]   Fasting glucose and progression of impaired glucose tolerance [J].
Cockram, CS .
DIABETES CARE, 1999, 22 (02) :369-370
[7]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[8]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[9]   Screening women with polycystic ovary syndrome for metabolic syndrome [J].
Dokras, A ;
Bochner, M ;
Hollinrake, E ;
Markham, S ;
VanVoorhis, B ;
Jagasia, DH .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :131-137
[10]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174